University of Alabama at Birmingham, UAB Hospital
Birmingham, Alabama 35294
4 studies enrolling now · 15 studies all time
What they study most
Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Alcoholic Hepatitis, Antibody-mediated Rejection, Arteriovenous Fistula, Arteriovenous Fistula Occlusion, Arteriovenous Fistula Stenosis, Atrial Fibrillation (AF), Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Fistula
Studies at this site
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis — Recruiting now
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) — Recruiting now
- Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
- Predicton of Sepsis Recovery Performance Subtypes Pilot Study — Recruiting now
- Trauma Resuscitation With Low-Titer Group O Whole Blood or Products — Recruiting now
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
- TTVR Early Feasibility Study — Running, not enrolling
- A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR) — Running, not enrolling
- Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
- Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx — Completed
- A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia — Stopped early
- Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
- Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys — Running, not enrolling
- A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment — Completed
- IN.PACT™ AV Access IDE Study — Completed